Home LiteratureArticle Details
PMID: 12093875 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa.

The Journal of experimental medicine ·Vol. 196 ·No. 1 ·2002-07-01 ·Pages 109-18

Hirakata Y, Srikumar R, Poole K, Gotoh N, Suematsu T, Kohno S, Kamihira S, Hancock RE, Speert DP

Abstract

Pseudomonas aeruginosa is an important opportunistic human pathogen. Certain strains can transmigrate across epithelial cells, and their invasive phenotype is correlated with capacity to cause invasive human disease and fatal septicemia in mice. Four multidrug efflux systems have been described in P. aeruginosa, however, their contribution to virulence is unclear. To clarify the role of efflux systems in invasiveness, P. aeruginosa PAO1 wild-type (WT) and its efflux mutants were evaluated in a Madin-Darby canine kidney (MDCK) epithelial cell monolayer system and in a murine model of endogenous septicemia. All efflux mutants except a deltamexCD-oprJ deletion demonstrated significantly reduced invasiveness compared with WT. In particular, a deltamexAB-oprM deletion strain was compromised in its capacity to invade or transmigrate across MDCK cells, and could not kill mice, in contrast to WT which was highly invasive (P < 0.0006) and caused fatal infection (P < 0.0001). The other mutants, including deltamexB and deltamexXY mutants, were intermediate between WT and the deltamexAB-oprM mutant in invasiveness and murine virulence. Invasiveness was restored to the deltamexAB-oprM mutant by complementation with mexAB-oprM or by addition of culture supernatant from MDCK cells infected with WT. We conclude that the P. aeruginosa MexAB-OprM efflux system exports virulence determinants that contribute to bacterial virulence.

MeSH Terms
Animals Bacterial Outer Membrane Proteins/genetics Bacterial Proteins/genetics Bacterial Translocation/genetics Carrier Proteins/genetics Cell Line Culture Media, Conditioned/pharmacology Disease Models, Animal Disease Progression Dogs Drug Resistance, Bacterial/genetics Epithelial Cells/cytology,microbiology,ultrastructure Gentamicins/pharmacology Kidney/cytology Membrane Transport Proteins Mice Microbial Sensitivity Tests Mutation Pseudomonas Infections/microbiology,pathology Pseudomonas aeruginosa/drug effects,pathogenicity,physiology Sepsis/microbiology,pathology Survival Rate Time Factors Virulence/drug effects,genetics
Chemicals
Bacterial Outer Membrane Proteins Bacterial Proteins Carrier Proteins Culture Media, Conditioned Gentamicins Membrane Transport Proteins MexA protein, Pseudomonas aeruginosa MexB protein, Pseudomonas aeruginosa
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Hirakata Yoichi
Division of Infectious and Immunological Diseases, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, V5Z 4H4 Canada. [email protected]
Srikumar Ramakrishnan
Poole Keith
Gotoh Naomasa
Suematsu Takashi
Kohno Shigeru
Kamihira Shimeru
Hancock Robert E W
Speert David P
References (59)
59 references, click to expand
  1. Small mobilizable multi-purpose cloning vectors derived from the Escherichia coli plasmids pK18 and pK19: selection of defined deletions in the chromosome of Corynebacterium glutamicum.
    Gene. 1994 Jul 22;145(1):69-73 PMID: 8045426
  2. Beta-lactamase inhibitors are substrates for the multidrug efflux pumps of Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 1998 Feb;42(2):399-403 PMID: 9527793
  3. Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability.
    Antimicrob Agents Chemother. 1999 Dec;43(12):2975-83 PMID: 10582892
  4. Efficacy of erythromycin lactobionate for treating Pseudomonas aeruginosa bacteremia in mice.
    Antimicrob Agents Chemother. 1992 Jun;36(6):1198-203 PMID: 1416819
  5. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment.
    Drug Resist Updat. 2000 Aug;3(4):247-255 PMID: 11498392
  6. Epithelial cell contact-induced alterations in Salmonella enterica serovar Typhi lipopolysaccharide are critical for bacterial internalization.
    Cell Microbiol. 2001 Nov;3(11):763-72 PMID: 11696036
  7. Overexpression of the MexEF-OprN multidrug efflux system affects cell-to-cell signaling in Pseudomonas aeruginosa.
    J Bacteriol. 2001 Sep;183(18):5213-22 PMID: 11514502
  8. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury.
    Mol Microbiol. 1997 Aug;25(3):547-57 PMID: 9302017
  9. The MexA-MexB-OprM multidrug efflux system of Pseudomonas aeruginosa is growth-phase regulated.
    FEMS Microbiol Lett. 1999 Apr 1;173(1):35-9 PMID: 10220878
  10. In vivo production of exotoxin A and its role in endogenous Pseudomonas aeruginosa septicemia in mice.
    Infect Immun. 1993 Jun;61(6):2468-73 PMID: 8500881
  11. Type III secretion machines: bacterial devices for protein delivery into host cells.
    Science. 1999 May 21;284(5418):1322-8 PMID: 10334981
  12. Identification and characterization of TnphoA mutants of Salmonella that are unable to pass through a polarized MDCK epithelial cell monolayer.
    Mol Microbiol. 1988 Nov;2(6):757-66 PMID: 2850443
  13. Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S.
    Infect Immun. 1997 Feb;65(2):579-86 PMID: 9009316
  14. Use of a transposon-encoded site-specific resolution system for construction of large and defined deletion mutations in bacterial chromosome.
    Gene. 1998 Jan 19;207(1):33-41 PMID: 9511741
  15. Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms.
    Antimicrob Agents Chemother. 2001 Jun;45(6):1761-70 PMID: 11353623
  16. Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections.
    Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):8822-8 PMID: 10922041
  17. Influence of the MexAB-OprM multidrug efflux system on quorum sensing in Pseudomonas aeruginosa.
    J Bacteriol. 1998 Oct;180(20):5443-7 PMID: 9765578
  18. Type III protein secretion systems in bacterial pathogens of animals and plants.
    Microbiol Mol Biol Rev. 1998 Jun;62(2):379-433 PMID: 9618447
  19. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon.
    J Bacteriol. 1993 Nov;175(22):7363-72 PMID: 8226684
  20. Relationship between cytotoxicity and corneal epithelial cell invasion by clinical isolates of Pseudomonas aeruginosa.
    Infect Immun. 1996 Jun;64(6):2288-94 PMID: 8675339
  21. Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa.
    Mol Microbiol. 1997 Jan;23(2):345-54 PMID: 9044268
  22. Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides.
    Antimicrob Agents Chemother. 1999 Nov;43(11):2624-8 PMID: 10543738
  23. Characterization of the MexC-MexD-OprJ multidrug efflux system in DeltamexA-mexB-oprM mutants of Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 1998 Aug;42(8):1938-43 PMID: 9687387
  24. Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 1992 Sep;36(9):1847-51 PMID: 1416876
  25. Expression of Pseudomonas aeruginosa multidrug efflux pumps MexA-MexB-OprM and MexC-MexD-OprJ in a multidrug-sensitive Escherichia coli strain.
    Antimicrob Agents Chemother. 1998 Jan;42(1):65-71 PMID: 9449262
  26. Improved broad-host-range plasmids for DNA cloning in gram-negative bacteria.
    Gene. 1988 Oct 15;70(1):191-7 PMID: 2853689
  27. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria.
    Clin Infect Dis. 1998 Aug;27 Suppl 1:S93-9 PMID: 9710677
  28. Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria.
    Antimicrob Agents Chemother. 2000 Sep;44(9):2233-41 PMID: 10952561
  29. The outer membrane protein OprM of Pseudomonas aeruginosa is encoded by oprK of the mexA-mexB-oprK multidrug resistance operon.
    Antimicrob Agents Chemother. 1995 Nov;39(11):2567-9 PMID: 8585747
  30. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections.
    Science. 1996 Jan 5;271(5245):64-7 PMID: 8539601
  31. PepA, a secreted protein of Pseudomonas aeruginosa, is necessary for cytotoxicity and virulence.
    Mol Microbiol. 1998 Feb;27(4):807-18 PMID: 9515706
  32. A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms.
    Antimicrob Agents Chemother. 2000 Mar;44(3):640-6 PMID: 10681331
  33. Interaction of Salmonella with host cells through the centisome 63 type III secretion system.
    Curr Opin Microbiol. 1999 Feb;2(1):46-50 PMID: 10047557
  34. Functional replacement of OprJ by OprM in the MexCD-OprJ multidrug efflux system of Pseudomonas aeruginosa.
    FEMS Microbiol Lett. 1998 Aug 1;165(1):21-7 PMID: 9711836
  35. Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract.
    J Immunol. 2001 Jun 15;166(12):7410-8 PMID: 11390493
  36. Rapid detection and evaluation of clinical characteristics of emerging multiple-drug-resistant gram-negative rods carrying the metallo-beta-lactamase gene blaIMP.
    Antimicrob Agents Chemother. 1998 Aug;42(8):2006-11 PMID: 9687398
  37. Plasmid vectors for selecting IS1-promoted deletions in cloned DNA: sequence analysis of the omega interposon.
    Gene. 1991 Jul 15;103(1):17-23 PMID: 1652541
  38. Multidrug resistance mechanisms: drug efflux across two membranes.
    Mol Microbiol. 2000 Jul;37(2):219-25 PMID: 10931319
  39. Genetic and physical mapping of genes involved in pyoverdin production in Pseudomonas aeruginosa PAO.
    J Bacteriol. 1995 Jan;177(2):423-31 PMID: 7814332
  40. Pseudomonas aeruginosa colonization of the gastrointestinal tract in patients with cystic fibrosis.
    J Infect Dis. 1993 Jan;167(1):226-9 PMID: 8418173
  41. Role of multiple efflux pumps in Escherichia coli in indole expulsion.
    FEMS Microbiol Lett. 1999 Oct 15;179(2):345-52 PMID: 10518736
  42. Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 1995 Sep;39(9):1948-53 PMID: 8540696
  43. Cloning and sequence analysis of an EnvCD homologue in Pseudomonas aeruginosa: regulation by iron and possible involvement in the secretion of the siderophore pyoverdine.
    Mol Microbiol. 1993 Nov;10(3):529-44 PMID: 7968531
  44. Inner membrane efflux components are responsible for beta-lactam specificity of multidrug efflux pumps in Pseudomonas aeruginosa.
    J Bacteriol. 1997 Dec;179(24):7875-81 PMID: 9401051
  45. Mortality rates amongst mice with endogenous septicaemia caused by Pseudomonas aeruginosa isolates from various clinical sources.
    J Med Microbiol. 1993 Aug;39(2):141-6 PMID: 8345509
  46. Antibiotic resistance caused by gram-negative multidrug efflux pumps.
    Clin Infect Dis. 1998 Aug;27 Suppl 1:S32-41 PMID: 9710669
  47. Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms.
    J Mol Microbiol Biotechnol. 2001 Apr;3(2):255-64 PMID: 11321581
  48. Adherence to and penetration of human intestinal Caco-2 epithelial cell monolayers by Pseudomonas aeruginosa.
    Infect Immun. 1998 Apr;66(4):1748-51 PMID: 9529107
  49. Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa.
    Mol Microbiol. 1996 Aug;21(4):713-24 PMID: 8878035
  50. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy.
    Antimicrob Agents Chemother. 2001 Jan;45(1):105-16 PMID: 11120952
  51. Characterization of Pseudomonas aeruginosa-induced MDCK cell injury: glycosylation-defective host cells are resistant to bacterial killing.
    Infect Immun. 1995 Apr;63(4):1541-51 PMID: 7890421
  52. Expression in Escherichia coli of a new multidrug efflux pump, MexXY, from Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 1999 Feb;43(2):415-7 PMID: 9925549
  53. Penetration of Salmonella through a polarized Madin-Darby canine kidney epithelial cell monolayer.
    J Cell Biol. 1988 Jul;107(1):221-30 PMID: 3292541
  54. Active efflux and diffusion are involved in transport of Pseudomonas aeruginosa cell-to-cell signals.
    J Bacteriol. 1999 Feb;181(4):1203-10 PMID: 9973347
  55. Sequence of a cluster of genes controlling synthesis and secretion of alkaline protease in Pseudomonas aeruginosa: relationships to other secretory pathways.
    Gene. 1992 Nov 2;121(1):47-54 PMID: 1427098
  56. Active efflux of bile salts by Escherichia coli.
    J Bacteriol. 1997 Apr;179(8):2512-8 PMID: 9098046
  57. Penetration of clinical isolates of Pseudomonas aeruginosa through MDCK epithelial cell monolayers.
    J Infect Dis. 2000 Feb;181(2):765-9 PMID: 10669373
  58. Salmonella typhi uses CFTR to enter intestinal epithelial cells.
    Nature. 1998 May 7;393(6680):79-82 PMID: 9590693
  59. Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils.
    Infect Immun. 2000 May;68(5):2916-24 PMID: 10768989
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
2002-07-01
Pages
109-18
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2194012
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]